We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock
DMTK

Delisted

DMTK was delisted on the 26th of June, 2024.

Back to rankings

22 hedge funds and large institutions have $70M invested in DermTech, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 1

144% more funds holding

Funds holding: 9 → 22 (+13)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

57% more capital invested

Capital invested by funds: $44.7M → $70M (+$25.3M)

Holders
22
Holders Change
+13
Holders Change %
+144.44%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$7.02M
2
Victory Capital Management
Victory Capital Management
Texas
+$5.69M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.09M
4
PVI
Pura Vida Investments
New York
+$3.79M
5
PA
Perceptive Advisors
New York
+$3.51M

Top Sellers

Rank Fund Capital Flow
1
CC
Centiva Capital
New York
-$151K
2
FCM
Farallon Capital Management
California
-$124K
3
UBS Group
UBS Group
Switzerland
-$5.54K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$29.1M +$2.63M +213,858 +9%
Victory Capital Management
2
Victory Capital Management
Texas
$8.67M +$5.69M +463,101 +151%
FCM
3
Farallon Capital Management
California
$6.81M -$124K -10,130 -2%
CC
4
Casdin Capital
New York
$5.64M +$7.02M +571,713 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$3.56M +$4.09M +333,333 New
PVI
6
Pura Vida Investments
New York
$3.48M +$3.79M +308,916 New
PA
7
Perceptive Advisors
New York
$3.21M +$3.51M +285,856 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.47M +$128K +10,431 +5%
MS
9
Maven Securities
Jersey
$2.42M +$2.64M +214,960 New
CAC
10
Cowen and Company
New York
$1.62M – – –
Millennium Management
11
Millennium Management
New York
$971K +$928K +75,593 +708%
Federated Hermes
12
Federated Hermes
Pennsylvania
$810K +$884K +72,004 New
MIM
13
Monashee Investment Management
Massachusetts
$536K +$585K +47,642 New
Goldman Sachs
14
Goldman Sachs
New York
$279K +$305K +24,815 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$246K +$269K +21,899 New
Bank of America
16
Bank of America
North Carolina
$109K +$119K +9,732 New
Morgan Stanley
17
Morgan Stanley
New York
$32K +$35K +2,852 New
WOC
18
West Oak Capital
California
$14K +$14.7K +1,200 New
WAM
19
Wolverine Asset Management
Illinois
$7K +$8.05K +656 New
Citigroup
20
Citigroup
New York
$4K +$4.46K +363 New
TRCT
21
Tower Research Capital (TRC)
New York
$1K +$1.09K +89 New
CC
22
Centiva Capital
New York
– -$151K -12,187 Closed
UBS Group
23
UBS Group
Switzerland
– -$5.54K -451 -98%

DMTK Hedge Fund Activity: Q1 2020 in Review

22 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2020, worth a combined $70M — up 57% from $44.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DMTK positions and 1 closed out — a net gain of 14 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Casdin Capital, opening a new position worth an estimated $7.02M. The largest seller was Centiva Capital, exiting entirely with an estimated $151K sold.

  • 22 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2020, up from 9 in Q4 2019.
  • Funds reported $70M of DermTech, Inc. Common Stock stock for Q1 2020, up 57% quarter-over-quarter.
  • 15 funds opened new DermTech, Inc. Common Stock positions in Q1 2020 and 1 closed out, a net change of +14 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q1 2020 was Casdin Capital, an estimated $7.02M added.
  • The largest DermTech, Inc. Common Stock seller in Q1 2020 was Centiva Capital, an estimated $151K sold.

Based on aggregated 13F filings for Q1 2020.